Login Register Cart 0
Generic placeholder image

Current Drug Research Reviews

Editor-in-Chief

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Biography

Meet Our Editorial Board Member

Author(s): Roberta Agabio

Volume 12, Issue 2, 2020

Page: [81 - 81] Pages: 1

DOI: 10.2174/258997751202201208095249

« Previous Next »
[1]
Pisanu C, Franconi F, Gessa GL, et al. Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis. Pharmacol Res 2019 Oct; 148104447 Epub 2019 Sep 6
[http://dx.doi.org/10.1016/j.phrs.2019.104447] [PMID: 31499196]
[2]
de Beaurepaire R, Sinclair J, Heydtmann M, Addolorato G, Aubin H, Beraha E. The Use of Baclofen as a Treatment for Alcohol Use Disorder. Front Psychiatry 9: 708.2019;
[http://dx.doi.org/10.3389/fpsyt.2018.00708]
[3]
Agabio R, Sinclair J, Addolorato G, Aubin H, Beraha E, Caputo F. Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. Lancet Psychiatry 5(12): 957-60.2020;
[http://dx.doi.org/10.1016/S2215-0366(18)30303-1]
[4]
Agabio R, Leggio L. Baclofen in the treatment of patients with alcohol use disorder and other mental health disorders. Front Psychiatry 9: 464.2018;
[http://dx.doi.org/10.3389/fpsyt.2018.00464]
[5]
Agabio R, Trogu E, Amato L, Pani PP. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Database Syst Rev 4CD0085812018;
[http://dx.doi.org/10.1002/14651858.CD008581.pub2]
[6]
Agabio R. Non-specialist health workers to treat excessive alcohol consumption and depression. Lancet 389(10065): 133-5.2017;
[http://dx.doi.org/10.1016/S0140-6736(16)32566-1]
[7]
Agabio R, Pisanu C, Gessa GL, Franconi F. Sex differences in Alcohol use disorder. Curr Med Chem 24(24): 2661-70.2017;
[http://dx.doi.org/10.2174/0929867323666161202092908]
[8]
Agabio R, Campesi I, Pisanu C, Gessa GL, Franconi F. Sex differences in substance use disorders: Focus on side effects. Addict Biol 21(5): 1030-42.2016;
[http://dx.doi.org/10.1111/adb.12395]
[9]
Agabio R, Leite-Morris K, Addolorato G, Colombo G. Targeting the GABAB receptor for the treatment of alcohol use disorder. In: GABAB Receptor; Ed Colombo G. Springer International Publishing Switzerland 287-307.2016;
[10]
Agabio R, Pani PP, Preti A, Gessa GL, Franconi F. Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review. Eur Addict Res 22(1): 1-16.2016;
[http://dx.doi.org/10.1159/000433579]
[11]
Agabio R, Colombo G. GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8: 140.2014;
[http://dx.doi.org/10.3389/fnins.2014.00140]
[12]
Agabio R, Preti A, Gessa GL. Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review. Eur Addict Res 19(6): 325-45.2013;
[http://dx.doi.org/10.1159/000347055]
[13]
Agabio R, Carai M A M, Gessa GL and, Colombo G. Gamma -Hydroxybutyric Acid (GHB). In: Koob GF, Le Moal M and, Thompson RF (eds). Encyclopedia of Behavioral Neuroscience Oxford: Academic Press Volume 2: 76-83.2010;
[14]
Agabio R, Marras P, Addolorato G, Carpiniello B, Gessa GL. Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. J Clin Psychopharmacol 27(3): 319-20.2007;
[15]
Agabio R, Colombo G, Carai MAM, Gessa GL. Novel pharmacotherapies and patents for alcohol abuse and alcoholism 1998-2001. Expert Opin Ther Patents 11: 1497-521.2001;

Rights & Permissions Print Cite
Article Metrics
10
© 2024 Bentham Science Publishers | Privacy Policy